Novartis AG (NVS)
163.07
+0.61
(+0.38%)
USD |
NYSE |
Sep 03, 16:00
163.07
0.00 (0.00%)
After-Hours: 20:00
Novartis Net Income (Annual) : 14.04B for Dec. 31, 2025
Net Income (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 14.04B |
| December 31, 2024 | 11.93B |
| December 31, 2023 | 8.572B |
| December 31, 2022 | 6.061B |
| December 31, 2021 | 24.02B |
| December 31, 2020 | 8.119B |
| December 31, 2019 | 7.147B |
| December 31, 2018 | 12.83B |
| December 31, 2017 | 7.703B |
| December 31, 2016 | 6.698B |
| December 31, 2015 | 7.028B |
| December 31, 2014 | 10.73B |
| December 31, 2013 | 9.343B |
| December 31, 2012 | 9.446B |
| December 31, 2011 | 9.149B |
| December 31, 2010 | 9.889B |
| December 31, 2009 | 8.421B |
| Date | Value |
|---|---|
| December 31, 2008 | 8.163B |
| December 31, 2007 | 6.54B |
| December 31, 2006 | 6.863B |
| December 31, 2005 | 6.062B |
| December 31, 2004 | 5.373B |
| December 31, 2003 | 5.023B |
| December 31, 2002 | 4.715B |
| December 31, 2001 | 4.171B |
| December 31, 2000 | 4.292B |
| December 31, 1999 | 4.445B |
| December 31, 1998 | 4.203B |
| December 31, 1997 | 3.605B |
| December 31, 1996 | 1.866B |
| December 31, 1995 | 3.580B |
| December 31, 1994 | 2.705B |
| December 31, 1993 | 2.376B |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Roche Holding AG | 16.62B |
| AstraZeneca PLC | 10.26B |
| Johnson & Johnson | 26.80B |
| Eli Lilly & Co. | 20.64B |
| Merck & Co., Inc. | 18.26B |